B M Baron

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.

John H. Kehne, B M Baron, A A Carr et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 359 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.

MG Erlander, Timothy W. Lovenberg, B M Baron et al. · Proceedings of the National Academy of Sciences · 1993 · 182 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site.

B M Baron, B.L. Harrison, Francis P. Miller et al. · Molecular Pharmacology · 1990 · 108 citations

Life Sciences, Neuroscience, Pharmacology +17

2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents

John M. Kane, B M Baron, Mark W. Dudley et al. · Journal of Medicinal Chemistry · 1990 · 96 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.

Timothy W. Lovenberg, MG Erlander, B M Baron et al. · Proceedings of the National Academy of Sciences · 1993 · 94 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +16